Filed Under:Health Insurance, Individual Health

Type 1 diabetes 'reverse vaccine' promises to let patients forget about insulin needles

from the Verge

Those who are suffering with Type 1 diabetes may be able to ditch the needles in the future, thanks to a new treatment that enables patients to produce their own insulin instead of having to inject it. Dr. Lawrence Steinman of Stanford University recently announced that the new treatment has passed its first human test, paving the way for wider use in the future.

The so-called "reverse vaccine" works by suppressing the immune system at the DNA level, which in turn stimulates insulin production. It could stand to be the first DNA-based vaccine approved for human use. ... 

To read the full article, click here.

Featured Video

Most Recent Videos

Behind the scenes with Vicki Gunvalson [VIDEO]

Provided by LIFEHEALTHPRO

In this exclusive interview, Vicki Gunvalson shares how she built a $15 million a year annuity business by planning for...

Regulator: Market may need to reinvent LTCI

Provided by LIFEHEALTHPRO

Cioppa says Maine's governor wants to spur the creation of better products.

Dementia: It's more than Alzheimer's

Provided by LIFEHEALTHPRO

An association calls for policymakers to remember lesser-known neurodegenerative conditions.

Protesters Disrupt WellPoint Annual Meeting

Provided by LIFEHEALTHPRO

Hecklers call for more disclosures of information about political contributions.

Related resources

More Resources

Comments

Power your business with up-to-the-minute insurance news, analysis, and best practices from LifeHealthPro Daily eNewsletter – FREE.

Power your business with LifeHealthPro Daily eNewsletter – FREE.

Enter a valid email address.
Close
Nichole Morford

Nichole Morford
Managing Editor

Thank you for subscribing to LifeHealthPro Daily!

Check Out More eNewsletters Now! Close

Advertisement. Closing in 15 seconds.